To Evaluate Whether Acetyl Salicylic Acid (Aspirin) and Darexaban (YM150) Interact in Their Effects

Clinical trial NCT01424332 · COMPLETED

Trial details

NCT number: NCT01424332
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pharmacodynamic and Pharmacokinetic Interaction Healthy Subjects

Start date: 2007-12-01
Primary completion: 2008-03-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.